147 studies found for:    Open Studies | "Nausea"
Show Display Options
Rank Status Study
21 Recruiting Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE
Conditions: Nausea;   Vomiting;   Metastatic Liver Cancer
Interventions: Device: acupoint electric stimulation;   Drug: tropisetron
22 Recruiting Ondissolve in the Prophylaxis/Rescue of Radiation Induced Nausea and Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Ondissolve;   Radiation: Palliative Radiation Therapy
23 Recruiting Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy
Conditions: Breast Cancer;   Nausea;   Vomiting
Interventions: Drug: granisetron transdermal system;   Drug: fosaprepitant dimeglumine;   Other: laboratory biomarker analysis
24 Unknown  Aprepitant for Prevention of Acute and Delayed Nausea and Vomiting in Patients Receiving a High-emetogenic Dose of Cyclophosphamide for Peripheral Blood Stem Cells Harvesting
Conditions: Nausea;   Vomiting
Interventions: Drug: Aprepitant, Palonosetron, Dexamethasone;   Drug: Placebo, Palonosetron, Dexamethasone
25 Unknown  Continuous Infusion of Palonosetron for Preventing of Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: continuous infusion of palonosetron added to prophylactic single injection of palonosetron;   Drug: continuous infusion of normal saline added to prophylactic single injection of palonosetron
26 Recruiting Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting
Conditions: Postoperative Nausea and Vomiting;   Vomiting
Interventions: Drug: Injection of Placebo (saline 0.9%);   Drug: Dexamethasone 3 mg intravenously;   Drug: Dexamethasone 6 mg;   Drug: Dexamethasone 12 mg
27 Not yet recruiting Study of Prevention of Postoperative Nausea and Vomiting Using Cesamet
Condition: Postoperative Nausea and Vomiting
Intervention: Drug: Nabilone
28 Recruiting Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and Vomiting
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Dexamethasone and Ondansetron;   Drug: Placebo
29 Recruiting Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting in Ambulatory Surgery
Condition: Postoperative Nausea and Vomiting
Intervention: Other: Ear seeds
30 Recruiting Use of Baxter Animated Retching Faces (BARF) Scale to Measure Nausea in Children Who Speak Spanish
Condition: Postoperative Nausea and Vomiting
Intervention:
31 Recruiting Single Dose Steroid Before Thyroidectomy for Benign Disease to Improve Postoperative Nausea, Pain, and Vocal Function
Conditions: Postoperative Pain;   Postoperative Nausea and Vomit;   Postoperative Vocal Function;   Thyroidectomy
Interventions: Drug: Dexamethasone;   Drug: saline solution;   Procedure: Thyroidectomy, total or partial
32 Recruiting A Single Dose of Intravenous (IV) Acetaminophen Verses Placebo in the Pre-operative Setting and Outcomes on Post-operative Pain, Nausea and Vomiting
Conditions: Post Operative Pain;   Post Operative Nausea and Vomiting
Interventions: Drug: IV acetaminophen;   Drug: placebo
33 Recruiting Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy
Conditions: Gastrointestinal Cancer;   Nausea Post Chemotherapy
Intervention: Drug: fosaprepitant dimeglumine
34 Recruiting Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Trimebutine Maleate (NEWBUTIN SR 300 mg Tab);   Drug: Metoclopramide hydrochloride monohydrate
35 Not yet recruiting Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy
Conditions: Hematopoietic/Lymphoid Cancer;   Nausea and Vomiting;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: Olanzapine;   Drug: Chemotherapy (cisplatin or cyclophosphamide and doxorubicin);   Drug: Antiemetic treatment (ondansetron or granisetron or palonosetron; plus dexamethasone; plus fosaprepitant or aprepitant);   Other: Placebo
36 Unknown  Efficacy and Safety Evaluation of Carbamazepine for Prevention of Chemotherapy-induced Nausea and Vomiting
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention: Drug: Carbamazepine
37 Recruiting Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention: Drug: Palonosetron, ondansetron, dexamethasone
38 Recruiting Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Condition: Radiotherapy-induced Nausea and Vomiting (RINV)
Interventions: Drug: SyB D-0701;   Drug: Placebo
39 Recruiting Fosaprepitant for Nausea and Vomiting During High-dose Interleukin-2 (HD IL-2) for Metastatic Melanoma and Renal Cell Carcinoma
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention: Drug: Fosaprepitant
40 Recruiting Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031 AM4)
Condition: Chemotherapy-Induced Nausea and Vomiting
Interventions: Drug: Fosaprepitant dimeglumine;   Drug: Fosaprepitant Placebo;   Drug: Dexamethasone;   Drug: Ondansetron;   Drug: Dexamethasone Placebo;   Drug: Ondansetron Placebo;   Drug: Rescue Therapy

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years